Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Teaching programs significantly improve adolescent girls' knowledge of PCOS.

Young women with PCOS without additional risk factors may have normal heart function.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Differentiating PCOS from NCAH helps improve diagnosis and treatment.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Custom-made consent forms for each plastic surgery procedure improve patient understanding and reduce legal issues.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

PCOS may increase the risk of mental health issues like depression and anxiety.

PCOS negatively affects women's quality of life, especially if not detected early.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

PepACS offers a safer, eco-friendly way to perm, dye, and repair hair.

Accurate diagnosis is crucial to distinguish between PCOS and rare ovarian tumors in teens with similar symptoms.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Ayurvedic treatments can help manage PCOS symptoms.

A new method improves platelet testing for heart disease patients.

Physician responses are better than ChatGPT for dermatology questions.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.